ORTEC expands German healthcare footprint with strategic acquisition of Klages & Partner
13.1.2026 09:00:00 CET | news aktuell GmbH | Press Release
Zoetermeer, Netherlands - 13 January 2026 - Acquisition adds over 200 healthcare customers and sector-specific workforce management expertise to ORTEC’s portfolio
ORTEC, a global leader in supply chain planning and workforce management software, today announced the strategic acquisition of Klages & Partner, a German developer of clinical staff management software for hospitals, clinics, and care facilities meeting the complex demands of modern healthcare. Klages & Partner serves over 200 healthcare customers, primarily in Germany.
This acquisition supports ORTEC’s Workforce Management strategic objective to strengthen its position in the German healthcare sector, building on decades of experience and established leadership in workforce scheduling for the Dutch healthcare market, as well as an existing customer base across Belgium, Finland, Germany, the United Kingdom, and Australia. It expands ORTEC’s German industry-specific expertise while maintaining focus on delivering clarity, reliability, and human-centric technology across its solutions portfolio.
“Klages & Partner shares our commitment, quite simply, to making work work better for people in complex operational environments,” said Georgios Sarigiannidis, CEO of ORTEC. “Together, we can offer healthcare organizations even more powerful, user-friendly tools to plan, manage, and optimize their workforce, ultimately improving care delivery and staff satisfaction.”
Founded in 1991, Klages & Partner develops and distributes software designed hand-in-hand with healthcare professionals to address the unique challenges of clinical staff planning. Their solutions simplify complex workforce scheduling while ensuring fairness, efficiency, and compliance, enabling hospital and care facility teams to focus on the work that matters most: patient care.
ORTEC and Klages & Partner have a shared commitment to customer value, practical innovation, and building solutions that genuinely support healthcare professionals. ORTEC brings long-standing experience in workforce scheduling for healthcare organizations, while Klages & Partner contributes deep local market knowledge and trusted relationships within the German care sector.
The transaction closed at the end of December 2025.
About Klages & Partner
Klages & Partner develops and distributes clinical staff management software in close collaboration with hospital professionals. Serving more than 200 customers, primarily in Germany, the company’s mission is to make workforce planning in healthcare effective, fair, and sustainable.
Contacts
Rebecca NobleVice President Corporate CommunicationsORTEC BV
Media Contact
Images
About ORTEC
For more than 40 years ORTEC builds software for planning supply chains and managing workforces. We help organizations figure out the best way to use their people and resources, even when things change. Using our trusted, AI-powered technology dissolves noise and friction so people can stay in the flow. Our goal is simple: let our software provide confidence, fairness, and reliability, so everyone can focus on the work that truly matters. ORTEC is backed by Battery Ventures. Discover more at ortec.com.
Subscribe to releases from news aktuell GmbH
Subscribe to all the latest releases from news aktuell GmbH by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from news aktuell GmbH
South Yemen: Why Peaceful Protests Are a Test of the International System’s Credibility16.2.2026 11:59:31 CET | Press Release
Analysis from western perspective by Podiomedia
Southern Yemen and the Test of an Emerging Democratic Experiment Analysis from a Western Perspective by Podiomedia16.2.2026 08:09:06 CET | Press Release
Al-Dhalea - In southern Yemen, the city of Al-Dhalea is preparing for demonstrations that could mark a defining moment in the relationship between popular will and political legitimacy. The planned gathering, framed by local leadership as a direct expression of public mandate, reflects an effort to anchor political authority in visible civic participation. When Aidarous al-Zubaidi declared the phrase “a pledge of men to men,” it was presented as a public commitment linking leadership directly to the people, transforming the anticipated rally into a clear expression of organized popular mandate. Organisers describe the mobilization as affirmation that political decisions must emerge from public will, not external arrangements or mediated agreements. The message accompanying the call - “no retreat, no compromises” - reinforces its framing as a structured assertion of legitimacy grounded in popular consent. Al-Dhalea itself carries symbolic and political significance. Long associated with
FEV analysis: TCO cut by up to 33 percent through range extender trucks11.2.2026 12:27:02 CET | Press Release
Aachen – FEV has published new analysis results on the economic efficiency of electrified commercial vehicles as part of an internal research program. The evaluation of extensive techno-economic data shows: depending on the driving cycle, through trucks with range extender architecture (REEV/Hybrid BEV) the total cost of ownership (TCO) can be reduced by up to 33 percent compared to conventional diesel trucks – while also significantly reducing CO₂ emissions. Even in the most unfavorable long-haul scenario, the TCO declined by approximately 14 percent.
BRP-Rotax: Aircraft Meets Racetrack – Luke Czepiela Flies the Racing Line at Bahrain International Circuit10.2.2026 17:00:00 CET | Press Release
BRP‑Rotax unveils its latest milestone in aviation with Aircraft Meets Racetrack. In an unprecedented accomplishment for the Bahrain International Circuit, Red Bull athlete and Rotax Ambassador Luke Czepiela became the first pilot to fly this Grand Prix track’s complete racing line from the air, showcasing the capabilities of Rotax powered aviation in a dramatic low‑level performance.
Grünenthal licenses exclusive Canadian rights to testosterone replacement therapy Nebido® to Apotex5.2.2026 16:03:03 CET | Press Release
Aachen, Germany & Toronto, Canada, February 5, 2026 – Grünenthal, a global leader in pain management and related diseases, and Apotex Inc. ("Apotex"), the largest Canadian-based pharmaceutical company, today announced they have entered into a licensing agreement whereby Apotex will have the exclusive Canadian rights to Nebido® (testosterone undecanoate), a long-acting injectable therapy indicated for the treatment of male hypogonadism (testosterone deficiency).[1] [1] https://www.medicines.org.uk/emc/product/14631/smpc
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom